PerkinElmer Inc., Natus Medical Incorporated and Trivitron Healthcare are Dominating the Global Newborn Screening Market in 2018

Global Newborn Screening Market is expected to grow at a healthy CAGR of 10.7% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below:

Access Full Report at

Global newborn screening market is a fragmented market which includes key players and local players. The market is growing owing to the favorable market scenario. The market has a prominent growth in upcoming years due to rising prevalence of newborn screening, growth in neonatal diseases and technological advancements in screening.

The market has witnessed developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand. For instance, In January 2017, PerkinElmer, Inc. had announced its acquisition with Tulip Diagnostics Private Limited. With this the company had developed its emerging market in diagnostics. It also enhances its ability to screen the infectious diseases. Hence there will be increased diagnostics portfolio around the globe.

PerkinElmer Inc. has dominated the global newborn screening market. The other key players existing in the market includes Natus Medical Incorporated, Trivitron Healthcare, Baebies, Inc., Bio-Rad Laboratories, Inc., Danahar, Hill-Rom Services Inc., Intelligent Hearing Systems, Interacoustics A/S, Masimo, Medtronic, Otodynamics Ltd, Vivosonic Inc., ZenTech S.A., among others.

PerkinElmer Inc.

PerkinElmer Inc. is headquartered in Massachusetts, U.S. was founded in 1947. The company is engaged in offering products and solutions for diagnostics, life sciences, and applied markets. The company operates through two business segments which include discovery & analytical solutions and diagnostics in which diagnostics is the market focused segment. The product categories of the company include accessories, consumables, informatics, instruments, OEM solutions, software and reagents in which instruments, reagents, software is market focused categories. The company has approx. 12,500 employees as of December 30, 2018.

  • In May 2019, PerkinElmer Inc. helped parent project Muscular Dystrophy launch a screening program for newborns for muscular dystrophy. It helps the company in increasing market value and market share by creating awareness for newborn screening.

The company has global networks through direct sales representatives and distributors in North America, South America, Asia-Pacific, Middle East and Africa, Europe. Its subsidiaries are Caliper Life Sciences (U.S.), ViaCord LLC (U.S.), PerkinElmer LAS GmbH (Germany), ViaCell, Inc. (U.S.), PerkinElmer Pty. Ltd (U.S.) and PerkinElmer SAS (U.S.).

Natus Medical Incorporated

Natus Medical Incorporated is headquartered in California, U.S. was founded in 1989. The company focuses on the development and commercialization of medical equipment and software for the neurology, hearing and balance assessment, neonatal screening and diagnosis and treatment of brain, nerves, muscles, balance, mobility and hearing. The company operates through three business segments as well as product categories which are Neuro, Newborn Care, Otometrics. Newborn Care is the market focused category and segment. The company has approx. 1,729 employees as of December 2018.

  • In July 2019, Natus Medical Incorporated announced an opening of new distribution channel in Gort, county Galway, Ireland. It helps in enhancing market share and market value, along with increase in customer channels for the company in the market.

It has its global networks through direct sales representatives and distributors in North America, Europe, Asia-Pacific and Latin America. Its subsidiaries are Bio logic Systems Corp (U.S.), Fischer Zoth Diagnose systeme GmbH (Germany), Natus Europe GmbH (Europe), Embla Systems, Inc. (U.S.), NeuroQuest LLC (U.S.) among others.

Trivitron Healthcare

Trivitron Healthcare headquartered in Tamil Nadu, India was founded in 1997. The company is engaged in providing affordable healthcare solutions to hospitals, individual healthcare providers, independent clinics and laboratories, extended care facilities and all other roofs.

The product categories of the company include newborn screening, mammography, radiography & C-Arm systems, ultrasound, breast biopsy system, operating room solution, ventilator, bone densitometer, contrast media, radiation protection, renal care, ICU solutions, clinical chemistry, hematology, immunology, electrophoresis, molecular diagnostics, chromatography and mass spectrometry, histopathology, microbiology, cytology, infectious disease, gastroentology, POC Metabolic test, radiology accessories. The newborn screening is market focused category.

  • In September 2017, Trivitron Healthcares’ Labsystems Diagnostics Oy and Baebies, collaborated to distribute a wider range of NBS solutions across several global markets. It helps in enhancing company’s portfolio, market share and market value.

It has its global networks through direct sales representatives and distributors in China, Finland, Germany, India, Japan, Nepal, Oman, Sri Lanka, Turkey, U.A.E.